Unleashing Chemical Intelligence
Discover moreAt InVirtuoLabs, we are revolutionizing drug discovery by seamlessly integrating cutting-edge artificial intelligence with molecular simulations. Our innovative platform combines advanced machine learning techniques—including multimodal learning, active learning, and generative chemistry—with physics-based simulations to explore vast chemical spaces with unprecedented efficiency.
By leveraging this powerful synergy, we are able to rapidly identify and optimize promising drug candidates, dramatically accelerating the path from concept to life-changing therapies.
Boldbrain 2024 Winners
Discover moreCutting-edge machine learning methods to swiftly evaluate a comprehensive range of critical properties for potential drug candidates. This innovative tool provides rapid, in-depth assessments of molecular properties, empowering our researchers to make data-driven decisions early in the design process.
By accelerating the identification of promising therapeutic compounds and enhancing the overall efficiency of drug discovery, our technology paves the way for faster development of innovative treatments.
90% reduction in processing time.
Success probability across clinical stages[1]
Generative AI is about reshaping the way we design drugs
Chief Executive Officer
Biomedical Engineer with a PhD in Computational Science. 10+ years as a researcher in the field of molecular simulations and machine learning. Principal Investigator of several national and international research projects.
Chief Operating Officer
30+ years of international experience in a wide array of managerial roles in the corporate and consulting universe. Expert in venture building and business development as investor, founder and ecosystem builder.
Molecular Modeling and Simulations
Biomedical Engineer with a PhD in Informatics. Expert in integrating enhanced molecular simulations for drug design applications.
Chief Commercial Officer
+25 years of experience as a pharma executive in CrossOver, PTC Therapeutics, Baxter, Pharma Nord, Novo Nordisk and Pfizer in Europe, Turkey and the USA.
AI for chemistry
AI for chemistry expert with 10+ years of experience in computer-aided drug discovery. Contributed to the development of several drug candidates for cancer, viral infections, and neurodegenerative diseases.
Chief Scientific Officer
30+ years in preclinical research and development. Former Director and Head of Innovation at Helsinn Healthcare SA. He worked in several pharmaceutical companies, including Recordati, Chiesi Pharmaceutical, and Glaxo Wellcome.
Generative Chemistry
Machine Learning Researcher with a PhD in particle physics and expertise in generative modeling, statistical analysis, and machine learning
Molecular Modelling and Machine Learning
Biomedical engineer with a strong background in molecular modelling for understanding biological mechanisms and machine learning for predicting molecular properties.
Development & Operations Engineer
Biomedical engineer with a strong background in signal processing, software engineering and biomedical instrumentation.